TS
RNAM

Twin Securities’s Avidity Biosciences RNAM Stock Holding History

Twin Securities’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-365,144
Closed -$26.3M – 24
2025
Q4 		$26.3M Buy
+365,144
New +$23.6M 10.07% 5

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Twin Securities's RNAM Position: Q1 2026 in Review

Twin Securities sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 365,144 shares — an estimated $26.3M sold.

Twin Securities first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $26.3M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Twin Securities reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Twin Securities sold 365,144 Avidity Biosciences shares in Q1 2026, an estimated $26.3M.
  • Twin Securities first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Twin Securities's Avidity Biosciences position peaked at $26.3M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Twin Securities's 13F filing for Q1 2026, filed 15 May 2026.